[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE409475T1 - Behandlung von fibromyalgie mit pindolol - Google Patents

Behandlung von fibromyalgie mit pindolol

Info

Publication number
ATE409475T1
ATE409475T1 AT02805691T AT02805691T ATE409475T1 AT E409475 T1 ATE409475 T1 AT E409475T1 AT 02805691 T AT02805691 T AT 02805691T AT 02805691 T AT02805691 T AT 02805691T AT E409475 T1 ATE409475 T1 AT E409475T1
Authority
AT
Austria
Prior art keywords
pindolol
treating fibromyalgia
fibromyalgia
treating
antagonist
Prior art date
Application number
AT02805691T
Other languages
English (en)
Inventor
T G Dinan
P W N Keeling
Original Assignee
Dinan Timothy Gerard
P W N Keeling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dinan Timothy Gerard, P W N Keeling filed Critical Dinan Timothy Gerard
Application granted granted Critical
Publication of ATE409475T1 publication Critical patent/ATE409475T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02805691T 2001-02-20 2002-02-20 Behandlung von fibromyalgie mit pindolol ATE409475T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26993701P 2001-02-20 2001-02-20

Publications (1)

Publication Number Publication Date
ATE409475T1 true ATE409475T1 (de) 2008-10-15

Family

ID=27734142

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02805691T ATE409475T1 (de) 2001-02-20 2002-02-20 Behandlung von fibromyalgie mit pindolol

Country Status (5)

Country Link
US (2) US6855729B2 (de)
EP (1) EP1383496B1 (de)
AT (1) ATE409475T1 (de)
DE (1) DE60229123D1 (de)
WO (1) WO2003065970A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002527378A (ja) * 1998-10-15 2002-08-27 インペリアル・カレッジ・イノベイションズ・リミテッド 治療方法
US8134029B2 (en) 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
AU2005283829A1 (en) * 2004-09-17 2006-03-23 Neurocure Ltd Pindolol for the treating premenstrual syndrome and premenstrual dysphoric disorder
US20080262071A1 (en) * 2004-09-17 2008-10-23 Timothy Dinan Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder
EP2455075B1 (de) 2005-07-06 2018-06-20 Sunovion Pharmaceuticals Inc. Prozess zur Herstellung von Trans-4-(3,4-dichlorphenyl)-1,2,3,4-tetrahydro-1-napthalenamin
GB0624282D0 (en) * 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
GB0907350D0 (en) * 2009-04-29 2009-06-10 Myotec Therapeutics Ltd Methods
JP2012526832A (ja) * 2009-05-13 2012-11-01 スノビオン プハルマセウトイカルス インコーポレイテッド トランスノルセルトラリン及びセロトニン受容体１ａ作動剤／拮抗剤を含む組成物及びその使用
WO2020101790A2 (en) 2018-09-04 2020-05-22 Minerva Neurosciences, Inc. Methods of using a phenoxypropylamine compound to treat pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (de) * 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
US5895787A (en) * 1997-10-08 1999-04-20 Designed Nutritional Products, Inc. Treatment of fibromyalgia and related disorders
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
PT957099E (pt) * 1998-04-15 2003-02-28 Pfizer Prod Inc Carboxamidas heterociclicas
US6331571B1 (en) * 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)

Also Published As

Publication number Publication date
WO2003065970A3 (en) 2003-11-20
DE60229123D1 (de) 2008-11-13
EP1383496B1 (de) 2008-10-01
US6855729B2 (en) 2005-02-15
WO2003065970A2 (en) 2003-08-14
US20040214877A1 (en) 2004-10-28
US20020165263A1 (en) 2002-11-07
EP1383496A2 (de) 2004-01-28

Similar Documents

Publication Publication Date Title
CY1117485T1 (el) Πολυθεραπεια για β-λεμφοκυτταρικες διαταραχες
CY1111194T1 (el) Ενωσεις πιπεριδινυλιου που επιλεκτικα προσδενουν ιντεγρινες
CY1112862T1 (el) Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα
CY1117124T1 (el) ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
CY1105014T1 (el) Ο συνδυασμος ενος αναστολεα επαναπροσληψης σεροτονινης κι ενος 5-ht2c ανταγωνιστη, αντιστροφου αγωνιστη ή μερικου αγωνιστη
DE69815090D1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69732868D1 (de) Mittel gegen Juckreiz
ATE465181T1 (de) Humanisierte anti-cmet-antagonisten
CY1110225T1 (el) Κυκλικοι αναστολεις πρωτεϊνικης τυροσινικης κινασης
NO20052221L (no) Fremgangsmater for behandling av smerte ved administering av en nervevekstfaktoragonist og et opioid smertestillende middel og preparater inneholdende dette
DK1355889T3 (da) Substituerede triazoldiaminderivater som kinaseinhibitorer
ATE250932T1 (de) Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer
NO20020837D0 (no) Fremgangsmåte til å identifisere egenskaper til stoff som påvirker prostaglandin D reseptorer
EA200000351A1 (ru) Лечение кондуктивных нарушений
NO20056134L (no) Kombinasjon av en NMDA-reseptorantagonist og en selektiv serotoningjenopptaksinbibitor for behandling av depresjon og andre sinnsstemningsforstyrrelser
EA200401160A1 (ru) Производные тиазола и оксазола, которые модулируют активность ppar
NO20040211L (no) Kombinasjon av en aldosteronreseptor for antagonist og en HMB COA-reduktaseinhibitor
DE60228567D1 (de) Behandlung von hyperlipidämie
DK1427409T3 (da) Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer
ATE409475T1 (de) Behandlung von fibromyalgie mit pindolol
EA200500783A1 (ru) Комбинация для лечения синдрома дефицита внимания с гиперактивностью
EA200401628A1 (ru) Ингибиторы пептидной деформилазы
DE602004004883D1 (de) Vegf-antagonisten zur behandlung von diabetes
ATE376419T1 (de) Carbostyril-derivate mit selektiven serotonin- aufnahme inhibitoren, zur behandlung von gemütskrankheiten
EA200500770A1 (ru) Конденсированные гетероциклические соединения

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties